| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,817 |
1,584 |
$107K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,589 |
1,364 |
$86K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
661 |
534 |
$57K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
547 |
466 |
$55K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,344 |
1,204 |
$42K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
714 |
650 |
$31K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
290 |
258 |
$19K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
233 |
165 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
440 |
368 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
230 |
166 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
31 |
31 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
66 |
45 |
$2K |
| 81025 |
|
540 |
445 |
$2K |
| 81003 |
|
959 |
823 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
130 |
127 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
26 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
22 |
13 |
$395.75 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16 |
16 |
$377.50 |
| 87807 |
|
38 |
25 |
$205.13 |
| 99051 |
|
340 |
328 |
$12.50 |